🇺🇸 FDA
Patent

US 9861600

Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment

granted A61KA61K31/00A61K31/07

Quick answer

US patent 9861600 (Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment) held by Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents, A Body Corporate Of The State Of Arizona Acting For An On Behalf Of The University of Arizona
Grant date
Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/00, A61K31/07, A61K31/195, A61K31/198